ATP6V0A2
|
0.200 |
Biomarker
|
disease |
BEFREE |
Our data will affect clinical management of patients with ATP6V0A2-related cutis laxa.
|
29952037 |
2019 |
ATP6V0A2
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
By studying molecular mechanisms of human disease-causing missense mutations within <i>a</i> subunit isoforms, we may identify domains critical for V-ATPase targeting, activity and/or regulation. cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 (<i>a</i>2) and ATP6V0A4 (<i>a</i>4) subunits and their mutants, <i>a</i>2<sup>P405L</sup> (causing cutis laxa), and <i>a</i>4<sup>R449H</sup> and <i>a</i>4<sup>G820R</sup> (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells.
|
29311258 |
2018 |
ATP6V0A2
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Three of the autosomal recessive cutis laxa syndromes, namely cutis laxa IIA (ARCL2A), cutis laxa IIB (ARCL2B), and geroderma osteodysplastica (GO), have very similar clinical features, complicating accurate diagnosis.
|
28294978 |
2017 |
ATP6V0A2
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Some of these conditions, including PMM2-CDG, frequently present with recognizable skin abnormalities such as abnormal fat distribution, skin wrinkling, or peau d'orange, whereas others, such as COG7-CDG and ATP6V0A2-CDG, have been described in association with cutis laxa: wrinkled, inelastic, and sagging skin.
|
24555185 |
2014 |
ATP6V0A2
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Through a survey of more than 20 patients with a specific subgroup of autosomal recessive congenital cutis laxa (ARCL), namely ATP6V0A2-related cutis laxa, we noted that the clinical findings on three patients included pretibial pseudo-ecchymotic skin lesions very similar to those found in classical Ehlers-Danlos syndrome.
|
24478233 |
2014 |
ATP6V0A2
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Autosomal recessive cutis laxa type I (ARCL type I) is characterized by generalized cutis laxa with pulmonary emphysema and/or vascular complications.
|
22829427 |
2013 |
ATP6V0A2
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The autosomal recessive form of type II cutis laxa (ARCL II) is characterized by the appearance of redundant, inelastic skin with wrinkling, an aged look and additional variable systemic involvement including intrauterine growth retardation, failure to thrive, developmental delay, dysmorphism, osseous abnormality, and CNS manifestations.
|
21567914 |
2011 |
ATP6V0A2
|
0.200 |
Biomarker
|
disease |
BEFREE |
A clinical overview of cutis laxa syndromes is presented with a focus on ARCL II.
|
19171192 |
2009 |
ATP6V0A2
|
0.200 |
Biomarker
|
disease |
BEFREE |
We present morphological and molecular genetic studies in a cutis laxa kindred with a previously undescribed highly variable phenotype caused by a novel ELN mutation c.1621 C > T. The proband presented with severe cutis laxa, severe congenital lung disease previously undescribed in ADCL and pulmonary artery disease, which is often seen in ARCL but rare in ADCL.
|
18348261 |
2008 |
ATP6V0A2
|
0.200 |
GeneticVariation
|
disease |
LHGDN |
Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2.
|
18157129 |
2008 |
ATP6V0A2
|
0.200 |
Biomarker
|
disease |
HPO |
|
|
|